Related Experiment Video

Updated: Sep 16, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

Therapeutic Potential of Ginsenosides in the Treatment of Endocrine Diseases: Roles and Mechanisms

Jing Li1,2, Hongyan Qiu1,2, Xiaoxiao Liu3

  • 1Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, China.

Phytotherapy Research : PTR
|July 8, 2025
PubMed

Insights

Ginsenosides from ginseng show promise in managing endocrine diseases. This review highlights their therapeutic potential for various endocrine disorders, paving the way for future clinical research.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Endocrine diseases represent a growing global health challenge with complex pathophysiology.
  • Current treatments focus on pharmacological agents to manage these disorders.
  • Ginseng-derived ginsenosides are bioactive compounds with potential therapeutic benefits.

Purpose of the Study:

  • To review recent research on the therapeutic applications of ginsenosides in endocrine disorders.
  • To explore the potential of ginsenosides for preventing and treating common endocrine diseases.
  • To provide insights for future clinical investigations into ginsenosides.

Main Methods:

  • Literature review of recent research studies.
  • Analysis of pharmacological data on ginsenosides.
  • Synthesis of findings on ginsenoside efficacy in endocrine disorder models.

Main Results:

  • Ginsenosides demonstrate beneficial properties for managing endocrine disorders.
  • Evidence suggests ginsenosides can be used for treatment and prevention.
  • Research indicates diverse therapeutic applications across various endocrine conditions.

Conclusions:

  • Ginsenosides hold significant therapeutic potential for endocrine diseases.
  • This review establishes a foundation for further clinical studies on ginsenosides.
  • Further research is warranted to fully elucidate the clinical utility of ginsenosides.
Keywords:
diabetesdiabetic complicationsendocrine diseaseginsenoside

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

474
Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments06:16

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments

Published on: May 9, 2019

7.7K

Related Concept Videos

The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
711
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.8K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
431
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
349
Structures of the Endocrine System00:59

Structures of the Endocrine System

The intricate framework of the endocrine system encompasses a diverse array of glands, with their target tissues and organs strategically distributed throughout the body. Central to this network are the endocrine glands, specialized structures that lack ducts and release hormones directly into the interstitial fluid. Notably, the hypothalamus, a vital neuroendocrine organ situated in the brain, governs neural functions and serves as a potent source of hormonal regulation. Near the hypothalamus...
8.5K